Advisory Services Network’s Cardiol Therapeutics CRDL Stock Holding History

Advisory Services Network’s Portfolio CRDL Stock Details CRDL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$13.5K	Buy	+10,000	New	+$10.3K	﹤0.01%	3401
2024 Q1	–	Sell	-3,458	Closed	-$2.92K	–	1894
2023 Q4	$2.92K	Buy	+3,458	New	+$2.94K	﹤0.01%	3283
2023 Q2	–	Sell	-3,458	Closed	-$1.69K	–	1895
2023 Q1	$1.69K	Hold	3,458	–	–	﹤0.01%	3479
2022 Q4	$1.76K	Buy	+3,458	New	+$2.11K	﹤0.01%	3480

Other funds holding CRDL

MMCAP International Grand Cayman, Cayman Islands $1.16B AUM 77.9% 1-Year Est. Return

Tejara Capital London, United Kingdom $303M AUM 5.43% 1-Year Est. Return

Ikarian Capital Dallas, Texas $1.23B AUM 600.17% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

Integrity Alliance Urbandale, Iowa $2.64B AUM 16.75% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Advisory Services Network's CRDL Position: Q1 2026 in Review

Advisory Services Network opened a new position in Cardiol Therapeutics (CRDL) in Q1 2026: 10,000 shares worth $13.5K. The stake represents ﹤0.01% of the portfolio and ranks #3401 among its holdings. This is a return to the name: Advisory Services Network previously reported a position in CRDL as recently as Q4 2023.

Advisory Services Network first reported a position in CRDL in Q4 2022 and has held it in 4 quarters since. 47 funds tracked by Wall St. Rank hold CRDL as of Q1 2026.

Advisory Services Network held 10,000 shares of Cardiol Therapeutics worth $13.5K as of Q1 2026.
Cardiol Therapeutics was a new Advisory Services Network position in Q1 2026.
Cardiol Therapeutics made up ﹤0.01% of Advisory Services Network's portfolio in Q1 2026, its #3401 holding.
Advisory Services Network first reported a position in Cardiol Therapeutics in Q4 2022 and has held it in 4 quarters since.
47 funds tracked by Wall St. Rank held Cardiol Therapeutics as of Q1 2026.

Based on Advisory Services Network's 13F filing for Q1 2026, filed 15 May 2026.